University of Texas/Texas AM Investment Management Co (UTIMCO) Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Illumina
ILMN
|
+$60M |
| 2 |
JPMorgan BetaBuilders MSCI US REIT ETF
BBRE
|
+$34.7M |
| 3 |
Denali Therapeutics
DNLI
|
+$2.36M |
| 4 |
Apple
AAPL
|
+$1.64M |
| 5 |
Amazon
AMZN
|
+$1.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Beam Therapeutics
BEAM
|
+$28.9M |
| 2 |
Vanguard Total World Stock ETF
VT
|
+$7.77M |
| 3 |
Taysha Gene Therapies
TSHA
|
+$4.64M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$594K |
| 5 |
Spyre Therapeutics
SYRE
|
+$167K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 58.89% |
| 2 | Technology | 4.56% |
| 3 | Consumer Discretionary | 0.73% |
| 4 | Communication Services | 0.1% |
| 5 | Industrials | 0.06% |
Similar funds
University of Texas/Texas AM Investment Management Co (UTIMCO)'s Q3 2021 Portfolio in Review
As of Q3 2021, University of Texas/Texas AM Investment Management Co (UTIMCO) held 45 positions worth $175M, up 34% from $130M the previous quarter. Its ten largest holdings account for 96% of the portfolio.
University of Texas/Texas AM Investment Management Co (UTIMCO) deployed $58.7M of net new capital in Q3 2021, opening 27 new positions and adding to 1 existing holding. Its largest new stake was Illumina: 130,457 shares worth $51.5M.
By sector, the portfolio is most concentrated in Healthcare at 59% of assets, down from 67% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard Total World Stock ETF, an estimated $7.77M trimmed.
- University of Texas/Texas AM Investment Management Co (UTIMCO)'s largest Q3 2021 buy was Illumina: 130,457 shares worth $51.5M.
- University of Texas/Texas AM Investment Management Co (UTIMCO) added most to Apple in Q3 2021, an estimated $1.64M increase.
- University of Texas/Texas AM Investment Management Co (UTIMCO)'s biggest Q3 2021 reduction was Vanguard Total World Stock ETF, cutting an estimated $7.77M.
- University of Texas/Texas AM Investment Management Co (UTIMCO) fully exited Beam Therapeutics in Q3 2021, selling an estimated $28.9M.
- University of Texas/Texas AM Investment Management Co (UTIMCO)'s ten largest holdings make up 96% of its $175M portfolio in Q3 2021.
- University of Texas/Texas AM Investment Management Co (UTIMCO) opened 27 new positions and closed 4 in Q3 2021.
- University of Texas/Texas AM Investment Management Co (UTIMCO)'s portfolio value rose 34% quarter-over-quarter to $175M.
Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q3 2021, filed 9 Nov 2021.